Chinese Journal of Schistosomiasis Control ›› 2024, Vol. 36 ›› Issue (5): 542-547.

Previous Articles     Next Articles

Progress of researches on toxoplasmosis vaccines based on the CRISPR/Cas9 technology

WU Yan1, 2, ZHANG Xin1, LI Jin1, XIE Jinjing1, WANG Longjiang1, SUN Hui1, 2*   

  1. 1 Shandong Institute of Parasitic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jining, Shandong 272033, China; 2 School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China
  • Online:2024-10-25 Published:2024-11-18

基于CRISPR/Cas9技术的弓形虫病疫苗研究进展

吴燕1, 2,张欣1,李瑾1,谢金晶1,王龙江1,孙慧1, 2*   

  1. 1 山东省寄生虫病防治研究所、山东第一医科大学(山东省医学科学院)(山东 济宁 272033);2 山东第一医科大学(山东省医学科学院)公共卫生与健康管理学院(山东 济南 250117)
  • 通讯作者: 孙慧sunhui123aq@126.com
  • 作者简介:吴燕,女,硕士研究生。研究方向:寄生虫病防治研究
  • 基金资助:
    山东省自然科学基金(ZR2022MH271);山东省医药卫生科技项目(202301011242);山东省医药卫生科技发展计划(202101050153)

Abstract: Toxoplasma gondii is an obligatory intracellular parasite which infects a variety of warm⁃blooded animals and causes toxoplasmosis. Toxoplasmosis seriously endangers human health and animal husbandry production. As one of the effective gene editing tools, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR⁃associated proteins (Cas) system has been widely used for knockout of genes in T. gondii. This review summarizes the applications of the CRISPR/Cas9 technology in vaccines against single⁃ and double⁃gene deletion strains of T. gondii, so as to provide insights into development of toxoplasmosis vaccines.

Key words: Toxoplasma gondii, CRISPR/Cas9 technology, Vaccine, Gene?deletion strain

摘要: 刚地弓形虫是专性细胞内寄生虫,可感染多种温血动物,引起弓形虫病。弓形虫病严重危害人体健康及畜牧业生产。成簇规律间隔短回文重复序列(clustered regularly interspaced short palindromic repeats,CRISPR)及其相关蛋白(CRISPR⁃associated protein,Cas)系统(CRISPR/Cas系统)是有效的基因编辑工具之一,广泛应用于弓形虫基因敲除。本文综述了CRISPR/Cas9技术在弓形虫病单基因和双基因缺失株疫苗研究中的应用,旨在为弓形虫病疫苗研制提供参考。

关键词: 弓形虫, CRISPR/Cas9技术, 疫苗, 基因缺失株

CLC Number: